Intratumoral injection of OK-432 suppresses metastatic squamous cell carcinoma lesion inducing interferon-γ and tumour necrosis factor-α

Clinical and Experimental Dermatology

Volumn 37, Issue 2, 2012, Pages 193-194

  Akeda, T ^a   Yamanaka, K ^a   Kitagawa, H ^a   Kawabata, E ^a   Tsuda, K ^a   Kakeda, M ^a   Omoto, Y ^a   Habe, K ^a   Isoda, K ^a   Kurokawa, I ^a   Mizutani, H ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CD3 ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 12; MONOCLONAL ANTIBODY CD28; PICIBANIL; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANIMAL CELL; CASE REPORT; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; KIDNEY DYSFUNCTION; LETTER; LYMPH NODE METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; HUMANS; INJECTIONS, INTRALESIONAL; INTERFERON-GAMMA; MALE; PICIBANIL; SKIN NEOPLASMS; TUMOR BURDEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857362828     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04151.x     Document Type: Letter

References (5)

1. Fujimoto T, Duda RB, Szilvasi A, et al. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state. J Immunol 1997; 158: 5619-26. (Pubitemid 127483964)
2. Shimizu T, Takahashi N, Terakado M, et al. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients. Intern Med 2006; 45: 715-20. (Pubitemid 44027602)
3. Ryoma Y, Moriya Y, Okamoto M, et al. Biological effect of OK-432 (picibanil) and possible application to dendritic cell therapy. Anticancer Res 2004; 24: 3295-301. (Pubitemid 39390944)
4. Inaba T, Yamanaka K, Asahi K, et al. Complete remission in a patient with angiosarcoma by the combination of OK-432, rhIL-2, and radiotherapy. Eur J Dermatol 2005; 15: 411-13. (Pubitemid 41337425)
5. Maeda K, Miura S, Kawamura M, et al. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin]. Gan To Kagaku Ryoho 1984; 11: 2434-7. (Pubitemid 15188691)